JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Launched by TAIPEI TZU CHI HOSPITAL, BUDDHIST TZU CHI MEDICAL FOUNDATION · Feb 20, 2023
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The patients with bladder cancer usually required trans urethral resection of bladder tumor (TUR-BT). Post-operative intravesical installation therapy is standard therapy. However, new onset lower urinary tract symptoms often occurred after these installation therapies. JING SI HERBAL TEA is a food contain of many herbal extracts with anti-inflammation effects. The current study is to find out the effects of JING SI HERBAL TEA in the treatment of this condition.
The patients will be divided into two groups by randomly assigned (estimated case number=100, experimental: control = 1: 1). The ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis bladder cancer
- • Under intravesical installation therapy
- Exclusion Criteria:
- • Patients under 20 years old or greater than 100 years old
- • Women with pregnancy or breastfeeding plans
- • Bladder cancer are being treated in another hospital
- • Had admitted due to other disease in the past 3 months
- • Unable to understand the questionnaire
About Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Taipei Tzu Chi Hospital, part of the Buddhist Tzu Chi Medical Foundation, is a leading healthcare institution in Taiwan dedicated to providing compassionate, high-quality medical care infused with Buddhist principles. Established to promote holistic healing and wellness, the hospital actively engages in clinical research to advance medical knowledge and improve patient outcomes. Committed to innovation and excellence, Taipei Tzu Chi Hospital collaborates with diverse stakeholders to conduct clinical trials that address critical health challenges, aiming to enhance the standard of care and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Shu-Yu Wu, bachelor
Study Director
Taichung Tzu Chi Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials